Treatment of sexually transmitted vaginosis/vaginitis. 1990

J G Lossick
Division of Sexually Transmitted Diseases/HIV, Centers for Disease Control, Atlanta, Georgia 30333.

Although much has been learned about sexually transmissible forms of vaginitis/vaginosis during the past decade, therapeutic options for these disorders remain limited. A single 2-g oral dose of metronidazole still remains highly effective against most Trichomonas vaginalis infections. Mildly resistant infections can usually be cured with metronidazole oral doses of 2 g daily for 3-7 days. When highly resistant infections occur, toxic levels of metronidazole may be needed for the drug to cure the infection. Metronidazole (500 mg twice daily for 7 days) continues to be highly efficacious in the treatment of bacterial vaginosis. Shorter oral treatment regimens that use single 2-g doses of metronidazole for 2-3 days appear promising but may be associated with higher relapse rates. Oral clindamycin (300 mg twice daily) or local 2% clindamycin cream (once daily for 7 days) also may be effective. Metronidazole intravaginal sponges (250-1,000 mg) used for 3 days may also be effective in the treatment of bacterial vaginosis.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D012747 Sexual Partners Married or single individuals who share sexual relations. Multiple Partners Sexual,Multiple Sex Partners,Multiple Sexual Partners,Sex Partners,Partner, Sex,Partner, Sexual,Sex Partner,Sex Partner, Multiple,Sex Partners, Multiple,Sexual Partner,Sexual Partner, Multiple
D012749 Sexually Transmitted Diseases Diseases due to or propagated by sexual contact. Venereal Diseases,STDs,STIs,Sexually Transmitted Infections,Disease, Sexually Transmitted,Disease, Venereal,Diseases, Sexually Transmitted,Diseases, Venereal,Infection, Sexually Transmitted,Infections, Sexually Transmitted,STI,Sexually Transmitted Disease,Sexually Transmitted Infection,Transmitted Infection, Sexually,Transmitted Infections, Sexually,Venereal Disease
D014247 Trichomonas Vaginitis Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS. Trichomoniasis, Human,Human Trichomoniases,Human Trichomoniasis,Trichomonas Vaginitides,Trichomoniases, Human,Vaginitides, Trichomonas,Vaginitis, Trichomonas

Related Publications

J G Lossick
December 1989, Current opinion in obstetrics & gynecology,
J G Lossick
October 2001, Sexually transmitted infections,
J G Lossick
January 1991, International journal of STD & AIDS,
J G Lossick
February 2001, Sexually transmitted infections,
J G Lossick
September 1984, Bollettino dell'Istituto sieroterapico milanese,
J G Lossick
September 1989, Clinics in laboratory medicine,
J G Lossick
December 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
J G Lossick
April 1982, American journal of obstetrics and gynecology,
Copied contents to your clipboard!